Sever Pharma expands work on ketamine implant with Silo Pharma
New phase of development targets chronic pain and fibromyalgia New phase of development targets chronic pain and fibromyalgia
Previous Post
Scotland approves zanubrutinib for relapsed mantle cell lymphoma
Next Post
Retired GP among health workers arrested at Palestine Action protest
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago